Compare POCI & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POCI | DOMH |
|---|---|---|
| Founded | 1982 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2M | 47.2M |
| IPO Year | 2008 | 2010 |
| Metric | POCI | DOMH |
|---|---|---|
| Price | $5.06 | $3.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.1K | ★ 167.7K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 23.45% |
| EPS Growth | N/A | ★ 34.03 |
| EPS | ★ N/A | N/A |
| Revenue | $19,091,269.00 | ★ $123,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $3.55 | $2.69 |
| 52 Week High | $6.04 | $8.40 |
| Indicator | POCI | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 67.22 | 45.06 |
| Support Level | $3.96 | $2.75 |
| Resistance Level | $5.32 | $3.45 |
| Average True Range (ATR) | 0.31 | 0.31 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 75.21 | 18.63 |
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.